Wixela vs Symbicort
What to choose Wixela or Symbicort
Wixela is inhaler of type Control while Symbicort is of Control type. Wixela and Symbicort are both brand inhalers. Wixela is manufactured by pharmaceutical company Viatris, while Symbicort is manufactured by AstraZeneca. The main substances of Wixela are Fluticasone and Salmeterol. The available dosage for Wixela is 250/50. The main substances of Symbicort are Budesonide and Formoterol. The available dosages for Symbicort are 100/6, 160/4.5, 200/6, 400/6.
The current price for Wixela is around $240 while current cost for Symbicort is roughly $359, said Dante Morgan, an Adjunct Professor at the Southern Illinois University and a Patient Representative at a clinic that uses Wixela and Symbicort.
Wixela and Symbicort Comparison
| Wixela | Symbicort | |
|---|---|---|
| Type: | Control | Control |
| Manufacturer: | Viatris | AstraZeneca |
| Substance: | Fluticasone + Salmeterol | Budesonide + Formoterol |
| Dosage: | 250/50 | 100/6, 160/4.5, 200/6, 400/6 |
| Avg Price: | $240 | $359 |